NOV 12, 2015 12:00 PM PST

Keynote: Optimizing the use of laboratory testing services to improve patient diagnosis

Speakers
  • Professor and Chairman, Department of Pathology, University of Texas Medical Branch-Galveston
    Biography
      Dr. Michael Laposata is the Professor and Chair of the Department of Pathology at the University of Texas Medical Branch-Galveston. He received his M.D. and Ph.D. from Johns Hopkins University School of Medicine and completed a postdoctoral research fellowship and residency in Laboratory Medicine (Clinical Pathology) at Washington University School of Medicine in St. Louis. He took his first faculty position at the University of Pennsylvania School of Medicine in Philadelphia in 1985, where he was an Assistant Professor and Director of the hospital's coagulation laboratory. In 1989, he became Director of Clinical Laboratories at the Massachusetts General Hospital and was appointed to faculty in the Department of Pathology at Harvard Medical School, where he became a tenured full Professor of Pathology. Dr. Laposata joined Vanderbilt University School of Medicine in 2008 where he was the Edward and Nancy Fody Professor of Pathology, Professor of Medicine, and the Pathologist-in-Chief.

      Dr. Laposata is the recipient of 14 major teaching prizes at Harvard, the Massachusetts General Hospital, and the University of Pennsylvania School of Medicine. His recognitions include the 1989 Lindback Award, a teaching prize with competition across the entire University of Pennsylvania system; the 1998 A. Clifford Barger mentorship award from Harvard Medical School; election to the Harvard Academy of Scholars in 2002, and to the Vanderbilt University School of Medicine Academy for Excellence in Teaching in 2009; and the highest award - by vote of the graduating class - for teaching in years 1 and 2 at Harvard Medical School in 1999, 2000, and 2005. In a peer nominated survey performed by The Pathologist, an international journal reporting on the practice of pathology, the November 2015 issue identified Dr. Laposata as the most influential pathologist in the United States, and the third most influential pathologist in the world.
    • Project Lead for Clinical Laboratory Integration into Healthcare Collaborative CLIHC, Division of Laboratory Science and StandardsLSPPPO, Centers for Disease Control and Prevention (CDC)
      Biography
        Julie received her B.S. degree in microbiology from the University of Alabama focusing on research in bacterial genetics then completed her M. S. and Ph.D. in microbiology at Auburn University where she studied immunity to bacteria and parasites. She gained experience in virology during a postdoctoral program at Emory University School of Medicine.

        Throughout her years of working in the private sector in laboratory and clinical research settings, Julie has identified, developed and completed programs addressing unmet needs in health care. Her accomplishments include patents and FDA- or USDA- licensed medical devices, vaccines, and diagnostics. She has developed both commercial and research diagnostics for detecting antigens, antibodies and cellular immunity.

        Julie's research experience includes the areas of virology, immunology, parasitology, mycology, genetics and oncology. She has worked nationally and internationally with professionals from hospitals, long term and home care institutions, academic institutions, medical device and pharmaceutical industries, State Public Health Departments, the World Health Organization, and the International Organization of Standards. She has also served as a reviewer for health care journals. These professional partnerships have resulted in journal publications, healthcare standards, and training programs.

        Julie is currently the Project Lead for the Clinical Laboratory Integration into Health Care Collaboration (CLIHC)TM from the Division of Laboratory Programs, Standards, and Services at the Centers for Disease Control and Prevention (CDC). She coordinates programs to improve laboratory quality by enhancing the capacity, infrastructure, and capabilities of laboratories worldwide.

      Abstract

      Diagnostic error impacts millions of US adults and children every year1,2.  Failure to order an appropriate diagnostic test and incorrect interpretation of diagnostic test results are common breakdowns in the diagnostic process3.  The Clinical Laboratory Integration into Healthcare Collaborative (CLIHC) TM, supported by the Division of Laboratory Systems at CDC, is addressing diagnostic error using several approaches.  The session will provide information on the frequency of the errors and the impact on patient outcomes.   Participants will learn about causes of diagnostic errors and strategies for reducing them.  Participants will also learn about CLIHCTM initiatives to identify gaps that exist in laboratory medicine training in medical schools and approaches being developed to promote appropriate test utilization, such as the use of test algorithms and mobile applications for test selection.    

      Learning Objectives:
      1)    Describe the frequency of diagnostic errors and the impact on patient outcomes
      2)    Discuss healthcare system failures that may contribute to diagnostic errors 
      3)    Identify at least three ways to reduce diagnostic errors 

      References:

      1. IOM. Improving Diagnosis in Health Care. Institute of Medicine, 2015.
      2. Singh, H, Meyer, A., Thomas, E,. The frequency of diagnostic errors in outpatient care: estimations from three large observational studies involving US adult populations. BMJ Qual Saf, 0: 1 – 5, 2014
      3. Strategies, C. Malpractice risks in the diagnostic process. 2014

      Show Resources
      You May Also Like
      SEP 10, 2020 9:00 AM PDT
      C.E. CREDITS
      SEP 10, 2020 9:00 AM PDT
      Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
      DEC 02, 2020 8:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      DEC 02, 2020 8:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
      JUN 09, 2020 10:00 AM PDT
      C.E. CREDITS
      JUN 09, 2020 10:00 AM PDT
      DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
      NOV 18, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 18, 2020 8:00 AM PST
      DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
      OCT 08, 2020 7:00 AM PDT
      C.E. CREDITS
      OCT 08, 2020 7:00 AM PDT
      DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
      OCT 29, 2020 6:00 AM PDT
      C.E. CREDITS
      OCT 29, 2020 6:00 AM PDT
      Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
      Loading Comments...
      Show Resources
      Attendees
      • See more